ストックスクリーナーアプリを入手
33.41
2.89%
0.94
アフターアワーズ：
33.48
0.07
+0.21%
前日終値:
$32.47
開ける：
$33
24時間の取引高:
13.28M
Relative Volume:
0.60
時価総額：
$7.61B
収益：
$1.78B
当期純損益:
$164.40M
株価収益率:
48.42
EPS:
0.69
ネットキャッシュフロー:
$236.51M
1週間 パフォーマンス:
-2.62%
1か月 パフォーマンス:
-7.99%
6か月 パフォーマンス:
-29.60%
1年 パフォーマンス:
+32.58%
1日の値動き範囲:
$32.05
$33.73
1週間の範囲:
$32.05
$34.75
52週間の値動き範囲:
$23.97
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
HIMS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
33.41 | 7.39B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
125.92 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.62 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.00 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.95 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
496.72 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-10-21 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | ダウングレード | Needham | Buy → Hold |
| 2025-06-04 | 繰り返されました | Needham | Buy |
| 2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-01-07 | 開始されました | BTIG Research | Buy |
| 2024-12-17 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-08-22 | 開始されました | Needham | Buy |
| 2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-10 | 開始されました | Canaccord Genuity | Buy |
| 2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | Imperial Capital | In-line |
| 2023-07-28 | 開始されました | TD Cowen | Outperform |
| 2023-04-11 | 開始されました | Robert W. Baird | Neutral |
| 2023-02-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-07-15 | 開始されました | SVB Leerink | Underperform |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | Deutsche Bank | Hold |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 開始されました | BofA Securities | Neutral |
| 2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 開始されました | Truist | Hold |
| 2021-03-09 | 開始されました | Credit Suisse | Neutral |
| 2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | 開始されました | Citigroup | Neutral |
| 2021-02-12 | 開始されました | Piper Sandler | Neutral |
| 2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
Promising Healthcare Stocks To Keep An Eye OnJanuary 4th - MarketBeat
Healthcare Stocks To ConsiderJanuary 1st - MarketBeat
Promising Healthcare Stocks To ConsiderJanuary 3rd - MarketBeat
Hims & Hers Health (NYSE:HIMS) Seems To Use Debt Rather Sparingly - simplywall.st
Best Healthcare Stocks To Watch NowJanuary 2nd - MarketBeat
The Biomarker Blood Testing Gold Rush Is Here - Athletech News
HIMS Stock On A Losing Spree: Here's Why - Forbes
Market Sentiment Sours for Hims & Hers Shares - AD HOC NEWS
Mixed options sentiment in Hims and Hers Health with shares down 2.47% - Yahoo Finance
2 Russell 2000 Stocks Worth Investigating and 1 We Avoid - Finviz
HIMS Stock Falls -8.7% With A 7-day Losing Spree On Valuation Concerns - Trefis
How Hims & Hers Health Inc. Class A (HIMS) Affects Rotational Strategy Timing - Stock Traders Daily
Best Healthcare Stocks Worth WatchingDecember 28th - MarketBeat
Healthcare Stocks To Watch TodayDecember 31st - MarketBeat
Unpacking the Latest Options Trading Trends in Hims & Hers Health - Benzinga
Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus - ts2.tech
Hims & Hers Faces Investor Scrutiny Amid Profitability Concerns - AD HOC NEWS
Hims & Hers Health, Inc. (HIMS) Dips More Than Broader Market: What You Should Know - sharewise.com
Notable Tuesday Option Activity: Z, UPS, HIMS - Nasdaq
Best Healthcare Stocks To Watch TodayDecember 30th - MarketBeat
HIMS Scales AI-Enabled Care as Platform Depth and Engagement Expand - Yahoo Finance
Hims Delivered 173% Returns Over Five Years but Recent Buyers Face 50% Losses - AOL.com
Hims & Hers Health (HIMS) Fell Due to Increased Regulatory Challenges - Insider Monkey
Hims & Hers Health Stock (HIMS) Opinions on Canadian Market Expansion - Quiver Quantitative
Top 10 Most Shorted Stocks: Lucid, MARA, Hims and More - Benzinga
TEM vs. HIMS: Which Medical Info Systems Stock Offers Greater Upside - Finviz
Hims & Hers stock slides into year-end as investors weigh Ohio buildout and macro calendar - ts2.tech
Returns Recap: Why hedge funds are buying Hims Hers Health Inc stockBuy Signal & Expert Approved Momentum Ideas - moha.gov.vn
Hims & Hers: A Growth Story Battling Market Skepticism - AD HOC NEWS
Carnegie Investment Counsel Acquires 61,560 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Top Healthcare Stocks To Follow TodayDecember 23rd - MarketBeat
How Do Investors Really Feel About Hims & Hers Health Inc? - Benzinga
Hims & Hers Health, Inc. (NYSE:HIMS) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Why Hims & Hers Health, Inc. (HIMS) Went Up On Wednesday? - MSN
Assessing Hims and Hers After Its 462% Multi Year Surge and Premium Valuation Multiple - Yahoo Finance
HIMS vs. TDOC: Which Telehealth Stock Looks More Compelling? - Finviz
The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health - The Globe and Mail
Hims & Hers Hit A GLP-1 Speed Bump This Year — But Growth Is Just Cooling, Not Cracking - Stocktwits
Hims & Hers Health Stock (HIMS) Opinions on Recent Volatility and Expansion - Quiver Quantitative
Voya Investment Management LLC Buys 52,370 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers quietly scooped up nearly 300,000 square feet in East Valley - The Business Journals
New Albany gains $200M health care expansion, 400 new jobs - Yahoo
Oluyemi Okupe Sells 23,090 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat
3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run - The Globe and Mail
Hims & Hers Expands Subscription-Led Care as Platform Engagement Grows - The Globe and Mail
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
How Novo Nordisk Is Trying to Regain Its Weight-Loss Edge - Bloomberg.com
Texas Permanent School Fund Corp Invests $2.57 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
(HIMS) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Is Hims & Hers Health’s US$200 Million Ohio Bet Quietly Redefining Its Core Strategy (HIMS)? - Yahoo Finance
2 Top Stocks to Buy With $500 Right Now - Yahoo Finance
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
2.19%
0.08%
大文字化:
|
ボリューム (24 時間):